ADAGE CAPITAL PARTNERS GP, L.L.C. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$267,057,600
+0.4%
9,840,000
+13.8%
0.61%
+4.8%
Q2 2023$265,901,000
+1.9%
8,650,000
+19.4%
0.58%
-1.2%
Q1 2023$261,032,558
-5.6%
7,244,867
+3.5%
0.58%
-11.6%
Q4 2022$276,640,000
-15.7%
7,000,000
-14.3%
0.66%
-18.7%
Q3 2022$328,070,000
-53.3%
8,165,000
-51.1%
0.81%
-49.4%
Q2 2022$702,397,000
-27.4%
16,707,815
-32.7%
1.61%
-12.4%
Q1 2022$967,872,000
-2.2%
24,842,7150.0%1.84%
+3.1%
Q4 2021$989,982,000
+10.9%
24,842,715
+0.6%
1.78%
+1.4%
Q3 2021$892,579,000
-4.2%
24,697,815
+8.7%
1.76%
-3.6%
Q2 2021$931,367,000
-13.5%
22,721,815
-8.0%
1.82%
-17.1%
Q1 2021$1,076,880,000
-44.4%
24,687,756
-36.2%
2.20%
-47.9%
Q4 2020$1,937,650,000
+0.1%
38,714,280
-15.9%
4.22%
-12.8%
Q3 2020$1,935,865,000
-13.3%
46,015,3300.0%4.85%
-15.3%
Q2 2020$2,234,044,00046,015,3305.72%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$244,378,00079.54%
Vantage Consulting Group Inc 7,862,542$284,152,00060.85%
Memorial Sloan Kettering Cancer Center 2,680,644$96,878,00060.36%
Indie Asset Partners, LLC 701,323$25,346,00020.53%
HARVARD MANAGEMENT CO INC 7,142,856$258,143,00015.13%
Bleichroeder LP 1,115,980$40,332,0006.55%
Overbrook Management Corp 785,132$28,375,0006.16%
Geo Capital Gestora de Recursos Ltd 194,305$7,022,0003.21%
Brown University 621,759$22,470,0003.05%
Graypoint LLC 610,584$22,067,0002.71%
View complete list of ROYALTY PHARMA PLC shareholders